ISPO

Chemotherapy

Treatment of malignant tumor (I stage) of alveolus and prevention of recurrence by the activation of immunodeficiency

M Ohkawa , K Ohkawa , R Ohkawa , T Ohkawa

Treatment of dysplasia of alveolus by activation of immunodeficiency

M Ohkawa , K Ohkawa , R Ohkawa , T Ohkawa

Tumor cell targeting with antibody-avidin complexes and biotin-TNF: a new approach for localizing TNF activity

A Corti PhD, M Moro PhD, G Fulci PhD, G Casorati PhD, G Paganelli MD, AG Siccardi MD, P Dellabona MD

Biostatistical issues in the toxicological evaluation of chemopreventive agents

CD Sherman PhD

Teratological models: relevance to mechanistic studies of anticancer drugs

A Torchinsky MD PhD DSci, S Savion PhD, M Gorivodsky MSc, J Shepshelovich MSc, I Ivnizky MSc, V Toder MD PhD

Gemcitabine: mechanism of action and clinical activity

V Heinemann

Mode of action of N-substituted benzamides and nicotinamides

RW Pero PhD, A Amiri, A Olsson, J Hua, T Ekberg, M Fata

The effect of fludarabine on fresh cells from patients with haematological malignancies

CG Taylor MRCPath. GM Lewandowicz BSc, JM Sargent BSc, AW Elgie BA, CJ Williamson HND

Attenuation of cardiotoxicity of daunomycin using a complex with heparin

Y Mizuno MD, H Kawaoto MD, T Hara MD

Antitumor activity of doxorubicin encapsulated in poly (ethylene glycol)-coated liposomes

J Hosoda, S Unezaki, K Maruyarna, M Iwatsuru

Antisense therapy for hepatocarcinoma

C Lafarge-Frayssinet PhD, J Trojan MD, HD Duc PhD, C Frayssinet PhD, A Sarasin PhD

Secondary tumors after chemotherapy treated sarcomas of bone

C Ferrari MSc, MS Benassi MSc, T Bohling MD, G Gamberi MSc, G Bacci MD, P Picci MD

Improvement of fosfomycin on therapeutic index of cisplatin and carboplatin

F Sampedro, P Santalo, J Rosello, E Marcuello, L De Andres

Biomodulation by hyperthermia of topoisomerase ii-targeting drugs in human colorectal cancer cells

K Hidaka MD, Y Hirohashi MD, S Sato MD, T Hisatsugu MD, K Miyazaki MD

Role of a topo II - inhibitor drug, etoposide, in the treatment of malignant gliomas: an experimental study

P Beauchesne MD, J Bonner MD, C Soler MD, F Mornex MD